✦ LIBER ✦
1474 POSTER A phase I, open-label study with escalating doses of intravenous PTK787/ZK 222584, a multi-VEGF receptor inhibitor, followed by multiple oral daily dosing to assess the absolute bioavailability of PTK787/ZK 222584 after single and multiple doses in advanced cancer patients
- Book ID
- 122681591
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 134 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.